NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cellworks Group Inc

Cellworks Group Inc

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://cellworks.life/

Last Round

Strategic

Jan 9, 2023

Total Funding Raised

$33.5M

Company Overview

Cellworks Group Inc is a biotechnology company that provides a biosimulation platform designed to predict therapy response for individual patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

biosimulationin silicoprecision medicinecomputational biologydigital twindrug discoveryclinical trial designpredictive analyticsmulti-omicsdrug response predictionclinical research organizationCROSaaS platformbiotech softwareAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellworks Group Inc Comparables

Compare Cellworks Group Inc with similar companies based on industry and business-model similarity.

Cellworks Group Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nova In Silico
84%
QuantHealth
84%
VeriSIM Life
81%

Cellworks Group Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 9, 2023
Series BDec 26, 2012
Series BOct 1, 2012
Series AMay 11, 2012

Key People

Founding team and executive leadership

Chinmaya Rath

Strategic Advisor To CEO

Executive Team

Brian Battey

Chief Operating Officer

Executive Team

Cellworks Group Inc Investors

Notable investors and investment history

Cellworks Group Inc investors
InvestorRounds
Agilent VenturesSeries B, Series A, Strategic
Sequoia CapitalSeries A, Series B, Strategic
Bering CapitalSeries B, Series A
ArtimanSeries B, Series A

Cellworks Group Inc Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellworks Group Inc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellworks Group Inc's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range163
Year Founded2005
Last FundingJan 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.